The pediatric healthcare landscape is seeing a shift due to the regulatory expansion of AI-enabled medical devices. These developments are redefining value creation across diagnostics, chronic disease management, and specialty access.

The US Food and Drug Administration (FDA) had authorized 1016 AI/ML-enabled medical devices that cover 736 unique products by December 2024. Yet only 17% of these devices are explicitly approved for pediatric use. Another 33.3% are adult-only, while 49.7% remain silent on pediatric applicability.

Children represent about one-quarter of the global population but remain underrepresented in AI-enabled medical device approvals.

At the same time, pediatric telehealth has moved from emergency adoption to structural integration. The market is projected to reach USD 126.98 billion by 2032, with a 20.5% compound annual growth rate (CAGR).

Meanwhile, hybrid care models are sustaining above pre-pandemic baselines, particularly in behavioral health and chronic disease management.

Innovations in Pediatric Healthcare

 

 

 

Several pediatric innovations focus on making child care safer and more effective, and improving access and quality of services.

AI Applications in Pediatric Care

Pediatric AI innovation is concentrating on high-acuity environments where predictive accuracy directly affects outcomes, workflow efficiency, and cost management.

Current commercial activity is strong in neonatal intensive care, imaging diagnostics, and population health analytics.

Clinical Decision Support

In a multi-center randomized trial of very low birthweight infants, displaying heart-rate characteristics (HRC) monitoring reduced mortality from 10.2% to 8.1%. The benefit was stronger in infants under 1000g, with mortality reduction from HRC display reflected in a hazard ratio of 0.74 and NNT of 23.

Leveraging AI for predictive monitoring of neonates reduces mortality, which directly affects hospital quality metrics, payer negotiations, and medico-legal exposure.

The private pediatric primary care group in the US, Pediatric Associates, deployed an AI-powered population health platform from Innovaccer in June 2024. The system unifies electronic health record (EHR), health information exchange (HIE), and payer data into prescriptive analytics dashboards.

Imaging Analysis

AI-enabled imaging tools are increasingly cleared under the 510(k) pathway. For example, BrightHeart’s View Classifier received FDA 510(k) clearance (K243684) for automated detection of standard fetal heart ultrasound views.

The prevalence of incremental 510(k) clearances indicates that pediatric AI imaging is advancing within existing modalities rather than creating entirely new device categories.

Predictive Analytics in Neonatal Care

Machine learning has been applied to predict bronchopulmonary dysplasia (BPD) in extremely low birthweight infants, achieving an AUC of 90%.

NICU costs per preterm infant can exceed six figures in developed markets. Predictive tools that shorten length of stay or prevent deterioration create measurable return on investment for tertiary children’s hospitals.

Pediatric Drug Discovery Tools

Only 90 920 of 462 303 registered clinical trials by August 2023 were pediatric-focused. The average time from study initiation to first patient consent in industry-sponsored pediatric drug trials is 239 days.

AI-driven trial modeling and rare disease targeting reduce these delays. These tools optimize site selection, patient matching, and dosing simulations to improve efficiency in pediatric drug development.

Pediatric Medical Device Innovations

Pediatric device innovation is shifting toward continuous monitoring, connected therapeutics, and miniaturized systems.

Neonatal Monitoring Systems

Neonatal device markets are expanding as NICUs standardize continuous vital tracking and work to reduce avoidable deterioration events. Respiratory monitoring and ventilation remain a significant segment within neonatal technology upgrades.

Consumer-to-clinical crossover is also emerging in infant monitoring. FDA-cleared wearables are entering prescription workflows. For instance, Owlet’s two products, Dream Sock and BabySat, received clearance and are available for clinical-grade infant pulse oximetry monitoring.

These developments indicate that neonatal monitoring systems are evolving across hospital and home settings.

Wearables for Chronic Pediatric Conditions

Chronic pediatric care relies on connected devices that support caregiver oversight and automated alerts rather than child self-management.

In pediatrics, continuous glucose monitors illustrate the “device + software + caregiver workflow” model. Leading systems emphasize real-time alerts and remote parental visibility.

Regional growth is also accelerating where regulators and manufacturers align around pediatric-grade wearables. Asia-Pacific is expected to post the fastest growth, with a 23.5% CAGR between 2025 and 2032 for FDA-cleared pediatric wearable devices.

Minimally Invasive Surgical Tools

Robotics is designed to fit pediatric anatomy and enable precision in oncology and complex procedures. A tertiary pediatric center reported that oncology accounted for 23% of its robotic surgeries, with 25% of tumors treated using a robotic platform. The center also had low complication and conversion rates.

Single-port robotic systems are expanding design options by combining single-site access with robotic dexterity. This approach is particularly relevant in pediatric oncology, where surgeons must operate within smaller working volumes.

Smart Respiratory Devices

Connected respiratory devices are expanding as pediatric care teams seek earlier deterioration signals and stronger home-to-clinic continuity.

Owlet partnered with Locus Health to integrate BabySat, a pulse oximetry monitoring system, into remote patient monitoring workflows for post-discharge care.

Digital Platforms for Pediatric Care Coordination

Digital pediatric platforms reduce friction in specialist access, shift routine demand away from hospitals, and keep caregivers engaged in the care workflow.

Remote Patient Monitoring

Companies are developing platforms that standardize pediatric care into defined visit types, which support hybrid delivery and remote follow-up. For example, Amazon One Medical launched a pay-per-visit virtual care option for children ages 2-11. The message visits start at USD 29, while video visits cost USD 49.

These models create repeatable demand units. Connecting to remote exam devices, longitudinal records, and follow-up care coordination makes pediatric care more structured and scalable.

Parent-Facing Digital Health Tools

To reduce avoidable emergency visits, parent-facing pediatrics is moving toward always-on support, messaging-first triage, and longitudinal care plans.

Summer Health raised USD 11.65 million in Series A funding in April 2024 to expand its pediatric telehealth service for parents.

In India, Babynama raised USD 700K in seed funding in February 2025, ensuring parents receive timely, reliable, and personalized care.

These tools create value when they integrate escalation pathways into clinics, remote exams, and specialist referrals, rather than operating as stand-alone chat services.

School-Integrated Health Systems

Schools are becoming a distribution layer for pediatric physical and mental health services because they address access, attendance, and consent logistics at scale.

Hazel Health reported expansion to 14 states, where it reached nearly 2.5 million students in more than 3000 schools. More than 10% of K-12 students in the states where the company operates have access to care at school and at home.

Key Innovators advancing Pediatric Landscape

Asthmaware makes Respiratory Wearables

Dutch startup Asthmaware develops a wearable respiratory monitoring system for pediatric hospital care. The device uses electromyography sensors to measure diaphragm activity and quantify shortness of breath continuously without active patient input.

It provides objective respiratory effort data, enables ongoing symptom monitoring, identifies the need for respiratory support early, and measures treatment response consistently.

Asthmaware supports clinical decision-making, reduces unnecessary hospital stays, and ensures safe patient discharge with reliable respiratory severity assessment.

Amira Therapeutics creates Targeted Therapies for Pediatric Cancers

Spanish startup Amira Therapeutics provides small-molecule drug candidates that inhibit tumor signaling pathways. These include CDON-related oncogenic adhesion processes and calcineurin/NFATc activation, both linked to tumor growth and metastasis.

The startup addresses rhabdomyosarcoma, brain cancers, and other solid tumors. Its lead candidate, AMI463, holds orphan drug designation from both the EMA and FDA. The drug is progressing in preclinical development with collaboration from pediatric hospitals.

Myoptechs builds a Vision Correction System

US-based startup Myoptechs builds optical correction technology for pediatric vision care. It applies its patented Faceted Optical System in contact lenses and glasses. This design generates peripheral myopic defocus, which slows excessive eye elongation while correcting distance vision.

The startup’s technology enables continuous management of progressive childhood myopia, supports early intervention, and allows children to transition between lenses and glasses as visual needs change.

Myoptechs works toward reducing long-term complications such as retinal damage and glaucoma, while supporting lifelong eye health management.

Nightingale Pediatrics advances Pediatric Mental Health

Singaporean startup Nightingale Pediatrics makes a telehealth platform for pediatric mental health care. It guides families with digital intake, assessment, intervention, and maintenance workflows. Clinicians use psychometric tests, digital screeners, and AI-assisted analytics on de-identified data to track progress and support diagnosis.

The platform delivers neurodevelopmental evaluations, behavioral screening, and therapy for children. It also offers coaching programs for parents and a 24/7 AI parenting coach for ongoing guidance.

Nightingale Pediatrics enables continuous mental health care and supports consistent decision-making beyond traditional clinic visits.

AVaTAR MedTech enables Valve Reconstruction

Argentinian startup AVaTAR MedTech develops surgical devices and a valve reconstruction method for semilunar heart valves. It utilizes single-use instruments to shape and implant a symmetrical valve from the patient’s own pericardial tissue in a semi-automatized and standardized surgical workflow.

This approach enables reproducible aortic and pulmonary valve reconstruction, avoids permanent implants, and reduces reliance on anticoagulation therapy. It also supports pediatric growth with an oversized, frame-free valve design.

AVaTAR MedTech improves surgical outcomes and long-term cardiac function for children and adults with valvular heart disease.

Global Pediatrics Market Size & Revenue Structure

The global pediatric healthcare market is projected to reach USD 32.48 billion by 2034. It will grow at an annual rate of 6.52%.

In terms of regional revenue distribution, North America accounted for about 41% of the global pediatric healthcare market in 2024.

Europe represents the second-largest pediatric healthcare region. This growth is supported by public healthcare infrastructure and regulatory incentives for pediatric drug development.

Asia-Pacific shows rapid expansion in pediatric pharmaceuticals and wearable medical devices. The pediatric drugs segment is projected to grow at an 18.3% CAGR.

Moreover, the global child health infrastructure is expanding with support from international agencies. UNICEF’s Humanitarian Action for Children 2025 calls for USD 9.9 billion across 146 countries, including USD 1.39 billion for health programs.

Investment Trends and Capital Allocation in Pediatrics

Pediatric-specific platforms are raising growth rounds to expand clinics and proprietary operating systems. Zarminali Pediatrics raised USD 110 million in Series A financing to grow its clinic footprint and technology platform. It reported 28 clinics across 8 states within two years of founding.

Great Hill Partners acquired a majority stake in Blue Cloud Pediatric Surgery Centers, which operates 32 accredited facilities across 12 states.

Home-based pediatric care is also consolidating as operators expand clinical capacity and geographic coverage. Aveanna Healthcare completed its acquisition of Thrive Skilled Pediatric Care on June 4, 2025, strengthening its private-duty nursing and home health footprint.

Strategic partnerships are forming around prenatal and pediatric imaging. Incumbents are acquiring regulated AI capability rather than building it internally. Samsung Medison signed an agreement to acquire Sonio, an AI company focused on prenatal ultrasound decision support.

Moreover, the US Department of Health and Human Services doubled the Childhood Cancer Data Initiative budget from USD 50 million to USD 100 million.

NIH-backed pediatric research capacity continues to highlight strong translational pipelines. Children’s Healthcare of Atlanta and Emory reported USD 59 million in NIH grant funding to the Emory Department of Pediatrics in FY2025.

Data Scope & Research Methodology

We created this analysis using data from StartUs Insights’ Discovery Platform. It maps innovation and execution signals across 9M+ companies, 25K+ technologies & trends, and 190M+ patents, news articles, and market reports.

The study focuses specifically on pediatric healthcare delivery, spanning neonatal intensive care and pediatric pharmaceuticals. Alongside, it covered connected medical devices, telehealth platforms, and school-based care systems.